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ABSTRACT  
We present a new method that combines alchemical transformation with physical pathway to accurately 
and efficiently compute the absolute binding free energy of receptor-ligand complex. Currently, the 
double decoupling method (DDM) and the potential of mean force approach (PMF) methods are widely 
used to compute the absolute binding free energy of biomolecules. The DDM relies on alchemically 
decoupling the ligand from its environments, which can be computationally challenging for large ligands 
and charged ligands because of the large magnitude of the decoupling free energies involved. On the other 
hand, the PMF approach uses physical pathway to extract the ligand out of the binding site, thus avoids 
the alchemical decoupling of the ligand. However, the PMF method has its own drawback because of the 
reliance on a ligand binding/unbinding pathway free of steric obstruction from the receptor atoms. 
Therefore, in the presence of deeply buried ligand functional groups the convergence of the PMF 
calculation can be very slow leading to large errors in the computed binding free energy. Here we develop 
a new method called AlchemPMF by combining alchemical transformation with physical pathway to 
overcome the major drawback in the PMF method. We have tested the new approach on the binding of a 
charged ligand to an allosteric site on HIV-1 Integrase. After 20 ns of simulation per umbrella sampling 
window, the new method yields absolute binding free energies within ~1 kcal/mol from the experimental 
result, whereas the standard PMF approach and the DDM calculations result in errors of ~5 kcal/mol and 
> 2 kcal/mol, respectively. Furthermore, the binding free energy computed using the new method is 
associated with smaller statistical error compared with those obtained from the existing methods. 
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INTRODUCTION 
Accurate prediction of binding affinity from the first principles of statistical thermodynamics is not only 
essential for understanding the physics of molecular recognition 1, but also important for supporting the 
structure based drug discovery 2. Among the several statistical thermodynamics based methods developed 
for computing the absolute binding free energy, including double decoupling method (DDM)3, the 
potential of mean force method (PMF),4 Metadynamics,5 the Binding energy Distribution method 
(BEDAM)6 and Mining Minima (M2),7 the DDM has been applied to many small to medium sized ligands 
with reasonably good accuracy. However, because DDM involves alchemically decoupling the ligand 
from its environments, i.e. from the receptor-ligand complex in solution and from free solution, the 
method has difficulty in treating the binding of large or charged ligands. For charged ligands, the 
electrostatic free energies from decoupling the ligand from the complex and that from the solution are 
both very large and favorable. The precise cancellation of the two very large, opposite terms, which is 
required to obtain accurate estimate of ∆𝐺𝑏𝑖𝑛𝑑
𝑜 , can be difficult to achieve.8 Furthermore, because DDM 
involves charge-charge decoupling between the ligand and its environment, complex corrections may be 
necessary to account for the errors caused by the use of finite sized, periodic solvent box.9 In addition to 
these problems for charged ligands, for large ligands, the convergence of the large Lennard-Jones 
decoupling free energies can also be very slow and contain large statistical errors. 
By using physical pathway to connect the bound state and the unbound state, the PMF approach avoids 
many of the aforementioned problems in DDM.8 However, a major problem of the PMF method is that 
the computation of the PMF depends on the existence of pathways free of major steric clash with the 
neighboring receptor residues.8 For larger ligands in more enclosed binding pockets, there is a high 
probability that certain atoms of the ligand will clash with the receptor atoms around the binding site at 
some point during the unbinding process. As a result, the convergence of the absolute binding free energy 
4 
 
can be very slow in these situations, resulting in very large errors in the apparent absolute binding free 
energy.8 
To improve the accuracy and efficiency of binding free energy calculations over the DDM and PMF 
methods, here we modify the thermodynamic cycle used in the conventional PMF method by introducing 
alchemical transformations within the physical pathway approach to avoid the potential steric clash 
between the unbinding ligand the receptor in the course of ligand pulling. After the ligand is pulled out, 
we add back the free energy cost associated with the alchemical steps in the calculation of the absolute 
binding free energy. We name the new method AlchemPMF. We have tested the new PMF method on a 
complex of a HIV-1 Integrase inhibitor carrying negative formal charge and compared the estimated 
absolute binding free energies from DDM, PMF and the new method. Compared with the existing PMF 
method and DDM, the new method yields significantly more accurate absolute binding free energy 
estimates and smaller statistical errors. 
 
MATERIALS AND METHODS 
 
 
Figure 1. The coordinate frame in which the orientation and the position of the ligand relative to the receptor are defined. The 
ligand position is defined in the polar coordinates by the distance raA and two angles : b-a-A;: c-b-a-A. The ligand 
orientation is defined by the three Euler angles: Θ: a-A-B; Ф: a-A-B-C; Ψ: b-a-A-B.  
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The simple PMF approach for absolute binding free energy  
The absolute binding free energy ∆Gbind
°  can be written as3 
  ∆Gbind
° = −𝑘𝐵𝑇 ln
𝑉
𝑉0
𝑍𝑅𝐿,𝑁𝑍0,𝑁
𝑍𝑅,𝑁𝑍𝐿,𝑁
= −𝑘𝐵𝑇 ln
𝑉
𝑉0
𝑍𝑅𝐿,𝑁
𝑍𝑅+𝐿,𝑁
    (1) 
Heree 𝑉0 =
1
𝐶𝑜
= 1660 Å2 is the inverse of the standard concentration of 𝐶𝑜 = 1 𝑀 solution. 𝑍𝑋,𝑁 
is the configuration integral (𝑍 = ∫ 𝑒−𝑈(𝑟)/𝑘𝐵𝑇𝑑𝑟) of a single solute X solvated in a box of volume V 
containing N waters. 𝑍𝑅𝐿,𝑁 represents a system containing one receptor-ligand complex in the bound 
state solvated by N water molecules, 𝑍𝑃+𝐿,𝑁 represents a system containing receptor R, an unbound 
ligand L and N waters, and 𝑍0,𝑁 represents a system of N solvent molecules.  
In the conventional PMF approach, the right hand side of Eq. (1) is evaluated by inserting intermediate 
states8, 10 
∆Gbind
° = −𝑘𝐵𝑇 ln
𝑉
𝑉0
𝑍𝑅𝐿,𝑁
𝑍𝑅+𝐿,𝑁
= −𝑘𝐵𝑇 ln
𝑉
𝑉0
𝑍𝑅𝐿,𝑁
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿,𝑁
  (2) 
Here 𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁  represents a bound complex RL in which the ligand L’s external degrees of 
freedom, which are defined by the polar angles (, ) and three Euler angles (Θ, Ф, Ψ), are restrained to 
their equilibrium values in the bound state by a set of harmonic restraints (𝑈𝜃, 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ): 𝑈𝜃 =
1
2
𝑘𝜃(𝜃 − 𝜃0)
2, 𝑈𝜙 =
1
2
𝑘𝜙(𝜙 − 𝜙0)
2, 𝑈Θ =
1
2
𝑘Θ(Θ− Θ0)
2, 𝑈Φ =
1
2
𝑘Φ(Φ− Φ0)
2, 𝑎𝑛𝑑 𝑈Ψ =
1
2
𝑘Ψ(Ψ−
Ψ0)
2 . Fig. 1 gives the definition of the polar angles (, ) and three Euler angles (Θ, Ф, Ψ). 
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁 represents a system in which the ligand L is subject to both the polar and orientational 
restraints (𝑈𝜃, 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ), and to the harmonic restraint 𝑈𝑟∗ =
1
2
𝑘𝑟(𝑟 − 𝑟
∗)2 , which forces the 
ligand atom A to be close to a bulk location r*. 
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Thus, the different terms inside the logarithm of the right hand side of Eq. (2) correspond to the 
following thermodynamic transformations (the corresponding 
thermodynamic cycle is illustrated by Fig. 2): 
The first term 
𝑍𝑅𝐿,𝑁
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
 corresponds to the free energy of 
switching on the angular restraints (𝑈𝜃, 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ) on 
the ligand when it is in the bound state, i.e. 
𝑍𝑅𝐿,𝑁
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
= 𝑒∆𝐺(𝜃,𝜙,Θ,Φ,Ψ)
𝑏𝑜𝑢𝑛𝑑 /𝑘𝐵𝑇   (3.1) 
This term is computed using free energy perturbation (FEP) on 
the bound complex by computing the free energy change of 
switching on the restraints (𝑈𝜃, 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ). 
The second term 
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
 equals to the ratio of the probability of an angularly restrained bound 
complex and the probability of an unbound, but “cross linked” receptor-ligand “complex”, in which the 
cross-linking is maintained by the restraints (𝑈𝑟∗ , 𝑈𝜃, 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ).  Let 𝑤(𝑟) be the 1D potential 
of mean force (PMF) along the raA axis. We have previously shown that
10  
  
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
=
∫ 𝑒−[𝑤(𝑟)−𝑤(𝑟
∗)]/𝑘𝐵𝑇𝑑𝑟𝑏𝑜𝑢𝑛𝑑
(
2𝜋𝑘𝐵𝑇
𝑘𝑟
)
1
2
     (3.2)  
Here the 1D PMF 𝑤(𝑟) is computed in the presence of the angular restraints (𝑈𝜃, 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ) 
from umbrella sampling, in which a series of MD simulations is performed with the harmonic distance 
restraint between the receptor atom a and ligand atom A.  
The last term 
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿,𝑁
 represents the free energy of removing all the distance and angular 
restraints (𝑈𝑟∗ , 𝑈𝜃, 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ) on the bulk ligand such that the ligand is allowed to occupy the 
standard volume 1/𝐶° and rotate freely. When the force constants used in the harmonic restraints are 
sufficiently strong, the rigid-rotor approximation applies, allowing this term to be evaluated analytically 
as10  
Figure 2. Thermodynamic pathway used by 
the standard PMF method for computing 
absolute binding free energy. 
 𝑤 𝑟∗
−∆𝐺𝑟𝑒  𝑟
𝑏  𝑘
Ligand
Receptor
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𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿,𝑁
≈
𝑟∗
2
 𝑖𝑛𝜃0 𝑖𝑛Θ0(2π𝑘𝐵T)
3
8𝜋2𝑉(𝑘𝑟𝑘𝜃𝑘𝜙𝑘Θ𝑘Φ𝑘Ψ)
1
2
    (3.3) 
where 𝜃0 and Θ0 are the equilibrium values of  and Θ, respectively.  
Substituting Eq. (3.1) through (3.3) into Eq. (2), we obtain the expression of ∆Gbind
°  in the standard 
PMF approach  
∆Gbind
° = −∆𝐺(𝜃,𝜙,Θ,Φ,Ψ)
𝑏𝑜 𝑛𝑑 − 𝑤(𝑟∗) − 𝑘𝐵𝑇 ln
∫ 𝑒−[𝑤(𝑟)−𝑤(𝑟
∗)]/𝑘𝐵𝑇𝑑𝑟𝑏𝑜𝑢𝑛𝑑
(
2𝜋𝑘𝐵𝑇
𝑘𝑟
)
1
2
− 𝑘𝐵𝑇 ln
𝐶𝑜𝑟∗
2
 𝑖𝑛𝜃0 𝑖𝑛Θ0(2π𝑘𝐵T)
3
8𝜋2(𝑘𝑟𝑘𝜃𝑘𝜙𝑘Θ𝑘Φ𝑘Ψ)
1
2
  (4) 
A new thermodynamic pathway to compute absolute binding free energy: AlchemPMF 
In the standard PMF approach, the interactions 
between the ligand and the receptor are not 
scaled. In a more enclosed binding pocket, the 
steric clash between certain atoms in the ligand 
and the receptor will lead to high energy barriers. 
Such high energy barriers will artificially inflate 
the computed value of the PMF in the bulk 
region 𝑤(𝑟∗) , since the protein residues 
involved in the clash will not have sufficient time 
to spontaneously sample the more open 
conformation within the tens of nanosecond timescale of the umbrella sampling.   
To avoid the interference of the high energy states arising from the atomic clashes, we insert an 
alchemical transformation in the thermodynamic cycle. We first identify the group of atoms in both the 
ligand and the receptor that will collide with each other along the unbinding pathway. These atoms are 
referred as clashing-causing-atoms. Then, in the new thermodynamic cycle (Fig. 3), after switching on 
the angular restraints (𝑈𝑟∗ , 𝑈𝜃 , 𝑈𝜙, 𝑈Θ, 𝑈Φ, 𝑈Ψ) , we alchemically turn off the pairwise interactions 
Receptor
Ligand
Decouple  
clash-
causing-
atoms
ligand 
extraction
A B
C
High energy clash No steric obstruction
D
ligand 
extraction
Figure 3. A→C represents he thermodynamic path in the 
standard PMF method, while A→B→D. is the thermodynamic 
path used in the new PMF method. 
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between these two groups of atoms only. Now we follow the standard procedure to pull the ligand out of 
the binding site along the chosen pathway, which will now be free from obstruction because of the 
previous alchemical transformation step. In the post-processing step, the free energy of turning off the 
pairwise interactions between the clash-causing atoms in the ligand and those in the receptor need to be 
included in calculation of the total absolute binding free energy. Fig. 3 illustrate the alchemical 
transformations in the new PMF method. Mathematically, this means that the Eq. (2) is modified by 
inserting two additional intermediate states, i.e. 
∆Gbind
° = −𝑘𝐵𝑇 ln
𝑉
𝑉0
𝑍𝑅𝐿,𝑁
𝑍𝑅+𝐿,𝑁
=
−𝑘𝐵𝑇 ln
𝑉
𝑉0
𝑍𝑅𝐿,𝑁
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅′𝐿′(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍
𝑅′𝐿′(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅′+𝐿′(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍
𝑅′+𝐿′(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿,𝑁
 
 (5) 
Here 𝑅′ and 𝐿′  represent the alchemically modified receptor and ligand in which the interactions 
between their clashing-causing-atoms are turned off. Comparing Eq. (5) with Eq. (2), two transformations 
are added: 
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅′𝐿′(𝜃,𝜙,Θ,Φ,Ψ),𝑁
 corresponds to the free energy change of alchemically switching off the 
pairwise interactions between clash-causing-atoms in the ligand and those in the receptor while the ligand 
is in the bound state. 
𝑍
𝑅′+𝐿′(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
 corresponds to the free energy change of alchemically switching 
on those interactions turned off in the bound state, when the ligand is unbound. Thus, the resulting 
expression for the ∆Gbind
°  becomes 
∆Gbind
° = −∆𝐺(𝜃,𝜙,Θ,Φ,Ψ)
𝑏𝑜 𝑛𝑑 − ∆𝐺𝑑𝑒𝑐𝑜 𝑝 𝑒
𝑏𝑜 𝑛𝑑 −𝑤(𝑟∗) − 𝑘𝐵𝑇 ln
∫ 𝑒−𝑤(𝑟)/𝑘𝐵𝑇𝑑𝑟𝑏𝑜𝑢𝑛𝑑
(
2𝜋𝑘𝐵𝑇
𝑘𝑟
)
1
2
− ∆𝐺𝑐𝑜 𝑝 𝑒
𝑏  𝑘 −
𝑘𝐵𝑇 ln
𝐶𝑜𝑟∗
2
 𝑖𝑛𝜃0 𝑖𝑛Θ0(2π𝑘𝐵T)
3
8𝜋2(𝑘𝑟𝑘𝜃𝑘𝜙𝑘Θ𝑘Φ𝑘Ψ)
1
2
          (6) 
where ∆𝐺𝑑𝑒𝑐𝑜 𝑝 𝑒
𝑏𝑜 𝑛𝑑 = −𝑘𝐵𝑇 ln
𝑍𝑅𝐿(𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅′𝐿′(𝜃,𝜙,Θ,Φ,Ψ),𝑁
 is the free energy of alchemically decoupling those 
clashing-causing-atoms in the bound state, and ∆𝐺𝑐𝑜 𝑝 𝑒
𝑏  𝑘 = −𝑘𝐵𝑇 ln
𝑍
𝑅′+𝐿′(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
𝑍𝑅+𝐿(𝑟∗,𝜃,𝜙,Θ,Φ,Ψ),𝑁
 is the free energy 
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of recoupling those clashing-causing-atoms when the ligand is unbound. Both terms are readily computed 
using FEP or TI. 
PMF calculation setup 
We compute the ligand 1D PMF 𝑤(𝑟) using umbrella sampling simulations in explicit solvent, in 
which a series of MD simulations is performed with the harmonic distance restraint on the receptor atom 
a and ligand atom A: see Fig. 1. The biasing potential in the i-th simulation window is 𝑈𝑟,𝑖 =
1
2
𝑘𝑟(𝑟 − 𝑟𝑖
0)2, where 𝑟𝑖
0 is the reference distance for the i-th sampling window. The full range of the 
distance space is covered using between 20 and 24 umbrella windows for the different complexes. A 
single force constant kr = 1000 kJ mol
-1 nm-2 is used for the distance restraint in all the sampling windows. 
The force constants used in the angular restraints are: 𝑘𝜃 = 𝑘𝜙 = 𝑘Θ = 𝑘Φ = 𝑘Ψ =
1000 𝑘𝐽 𝑟𝑎𝑑−1𝑚𝑜𝑙−1 . In each umbrella window, a 30-ns MD simulation is performed, starting from 
the last simulation snapshot of the previous window. The biased probability distributions along the 
distance r accumulated in these sampling windows are unbiased and combined using the Weighted 
Histogram Analysis Method (WHAM) method to yield the unbiased distribution and the potential of mean 
force 𝑤(𝑟)  The WHAM program implemented by Grossfield is used to calculate the PMF. Five 
independent umbrella sampling simulations were preformed and the statistical uncertainties in the 
calculated PMF are estimated by the standard deviation of the results obtained from these independent 
umbrella sampling simulations. The total simulation time used to compute the PMF for a single receptor-
ligand complex is ~2.1 s. 
The paths along which ligands are pulled out in the PMF calculation are identified by trial and error. 
First, a ligand atom A and a protein atom a are chosen to define axis 𝒓𝒂𝑨; using the Discovery Studio 
Visualizer (Biovia Inc), the ligand is translated manually along this axis with its orientation relative to the 
receptor fixed. If the unbinding ligand collides with the nearby protein atoms, (a clash is shown as red 
dashed line in the DS Visualizer), then a different set of atom pairs will be tried. After a few tries, one or 
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more low energy paths may be identified; these paths are then used to run umbrella-sampling simulation 
to get PMF. For BI-224436, we identified two low free energy paths, with the ∆Gbind
°  estimated using 
path 2 lower than that from path 1. The PMF result reported here are for the lowest free energy paths. 
MD Simulation Setup 
In this work, the MD free energy simulations were performed using the GROMACS 4.6.4.11 The atomic 
coordinates of the bound complex of HIV-1 integrase and the ligand BI-224436 was obtained using the 
Glide docking program from the Schrodinger Inc..12 BI-224436 is known to bind at the catalytic core 
dimer interface of HIV-1 integrase.13 Therefore, the crystal structure of the HIV-integrase in complex 
with a similar ligand BI-D14 is used as the template for Glide docking of the BI-224436. The AMBER 
parm99ILDN force field15 is used to model the HIV-1 integrase catalytic core dimer, and the Amber 
GAFF parameters set16 and the AM1-BCC charge model17 are used to describe the ligand BI-224436. 
TIP3P water18 boxes previously equilibrated at 300 K and 1 atm pressure were used to solvate the protein-
ligand complex. The dimension of the solvent box is set up to ensure that the distance between solute 
atoms from nearest walls of the box is at least 10 Å. To maintain charge neutrality, 1 Cl- and 1 Na+ are 
added to the solvent boxes containing the protein-ligand complex and that containing the ligand, 
respectively. The electrostatic interactions were computed using the particle-mesh Ewald (PME)19 method 
with a real space cutoff of 10 Å and a grid spacing of 1.0 Å. MD simulations were performed in the NPT 
ensemble with a time step of 2 fs.  
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RESULTS AND DISCUSSIONS 
 
Figure 4.The allosteric HIV-1 Integrase inhibitor BI-224436. Left: the original ligand. Right: a mutated form in which the 
bulky tricyclic group is decoupled from the environment. 
 
Figure 5. Left: The charged ligand BI-224436 in the allosteric site of the HIV-1 Integrase catalytic core domain dimer. Right: 
The PMF of pulling the unmodified BI-224436 out of the binding pocket of HIV-1 integrase. 
We test the new AlchemPMF method by applying it to compute the absolute binding free energy of an 
allosteric HIV-1 Integrase inhibitor BI-224436 (Fig.2), which carries a negative charge at pH 7. In this 
ligand, the calculation of ∆Gbind
°  by using the regular PMF method Eq. (4) is hampered by the presence 
of the bulky tricyclic group, which clashes with the side chain residues around the binding pocket when 
the ligand unbinds (Fig.4 and Fig. 5). The steric clash experienced by the unbinding ligand led to large 
error bars in the calculated PMF of pulling the unmodified BI-224436 out of the binding pocket of HIV-
1 integrase: see Fig. 5, right panel. As a result, the ∆Gbind
°  computed using the simple PMF converges 
slowly: even with 30 ns of simulation in each of the umbrella sampling window (total simulation time: 24 
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× 30 = 720 ns) the PMF-calculated ∆Gbind
°  is still about -3.3 kcal/mol more favorable than the 
experimental result from SPR measurement: see Table 1 and Fig. 6.  
Using the new method AlchemPMF, we first alchemically modify the ligand in the bound state by 
turning off the nonbonded interaction between the tricyclic group of the ligand and its environment, and 
then using umbrella sampling to pull the modified ligand out of the binding pocket. Note that other 
interactions are not modified, including the ligand intramolecular interaction with the tricyclic group. 
When the ligand is in the bulk solution, we re-couple the disappeared tricyclic group to its environment. 
Finally, the ∆Gbind
°  is computed by using the Eq. (6). As seen from Table 1 and Fig. 6, the ∆Gbind
°  
computed from the new procedure converges significantly faster to the experimental result. At t = 20 ns 
for each of the umbrella sampling windows, the ∆Gbind
°  computed using Eq. (6) is within 1.2 kcal/mol 
from the experiment, whereas that the result from regular PMF deviates from the experimental result by 
~ 5.2 kcal/mol. Fig. 7 shows the PMF computed using the alchemically modified ligand L’, i.e. the right 
panel of Fig. 4. Compared with the computed PMF for the unmodified ligand (Fig. 5, right panel), the 
error bars in the PMF function for the alchemically modified ligand is substantially smaller: see Fig. 7. 
Clearly, by alchemically “hiding” the clash-causing-atoms in the ligand, the steric clash with the receptor 
in the course of ligand pulling has been largely avoided, which leads to significantly improved binding 
free energy estimates and smaller statistical errors. 
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Table 1. Comparisons of the absolute binding free energy for BI-224436 from different methods and using 
different simulation time segments. Unit: kcal/mol. 
∆𝐺𝑏𝑖𝑛𝑑
𝑜 at 
different time 
segmentsa 
simple PMFa AlchemPMFb DDM Experimentc 
0 -10 ns -18.14 ± 0.89 -15.51 ± 1.76 
-12.54 ± 0.3 -10.33 10 - 20 ns -15.35 ± 1.25 -11.38 ± 1.17 
20 - 30 ns -13.75± 2.48 -10.33 ± 1.06 
a. The ∆𝐺𝑏𝑖𝑛𝑑
𝑜  obtained using different simulation time segments in each umbrella sampling window 
for simple PMF and AlchemPMF. 
b. Computed using Eq. (4) in the Method. 
c. Computed using Eq. (6) in the Method. 
d. From SPR measurement, to be published result from Mamuka Kvaratskhelia lab. 
 
 
Figure 6. Computed absolute binding free energy as a function of the umbrella sampling simulation time using the simple PMF 
approach Eq. (4) and AlchemPMF expression Eq. (6). 
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Figure 7. The PMF of pulling the alchemically modified BI-224436 out of the binding pocket of HIV-1 integrase. 
 
CONCLUSIONS 
The PMF approach is a powerful method for computing absolute binding free energy 4, 20, especially in 
treating binding problems involving charged ligands 8, 10. In practice, however, the PMF method is not 
suitable when the binding site is significantly enclosed; this is because a converged calculation of the 
PMF depends on the existence of a ligand extraction pathway that is free of steric obstruction from 
receptor atoms. To overcome this major limitation in the standard PMF method, we develop a novel 
method called AlchemPMF, by combining alchemical transformation with physical pathway to remove 
steric obstruction in the calculation of PMF. Our test results on the binding of a charged HIV-1 integrase 
ligand with a buried functional group demonstrates that the AlchemPMF leads to significantly improved 
absolute binding free energy estimates and smaller statistical errors compared with those given by the 
simple PMF method and DDM. The new method is expected to allow a broader range of binding problems 
to be treated accurately, including protein-protein and protein-DNA complexes, which involve larger and 
more complex binding interfaces compared with those in the protein-small molecule complexes.  
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